Video Library
The Future of ASCVD and Lipidology with Prof. Cannon
In this video, Prof. Christopher Cannon explored the future of ASCVD and lipidology. He talks about the recent expanded indication for evlocumab and new indication for inclisiran, upcoming guidelines on LDL management, the development of oral PCSK9 inhibitors, CETP inhibitors, upcoming trials on Lp(a), and strategies for managing triglycerides.
Prof. Christopher Cannon
First published: October 6, 2025
Video Library
Treatment Persistence and Non-Adherence in Atherosclerotic Cardiovascular Disease
In this video, Prof. Christopher P. Cannon presents an infographic on treatment persistence and non-adherence in Atherosclerotic Cardiovascular Disease.
Prof. Christopher P. Cannon
First published: July 16, 2025
Video Library
Role of Eicosanoids in Atherosclerosis, with a Focus on Icosapent Ethyl (IPE) as a Therapeutic Option for Cardiovascular Disease
In this video, Prof. Deepak L. Bhatt presents an infographic on the role of eicosanoids in atherosclerosis with a focus on IPE as therapeutic option for CVD.
Prof. Deepak L. Bhatt
First published: May 29, 2025
Video Library
The Emerging Role of Inclisiran in Atherosclerotic Cardiovascular Disease Management
Welcome to our latest video! This video explores the emerging role of inclisiran, a small interfering RNA (siRNA) therapeutic that targets PCSK9, in the management of atherosclerotic cardiovascular disease. The summary delves into the mechanism of actions of inclisiran, its safety profile, results from clinical trials and the latest data presented at the ESC congress.
First published: January 13, 2025